...Good morning, and welcome to Recursion Pharmaceuticals 2024 Annual Meeting of Stockholders. I am Christopher Gibson, Co-Founder and Chief Executive Officer of Recursion and a member of the Board of Directors. I will preside as Chair of this meeting, which I now call to order. This meeting is being conducted in a virtual meeting format only via the Internet. I am pleased to welcome you here today on behalf of the Board of Directors, some of whom are present at the meeting. The other members of the Board are Martin Chavez, Zachary Bogue, Blake Borgeson, Terry-Ann Burrell, Zavain Dar, Robert Hershberg, Najat Khan, and Dean Li. Joining me today from management, we have Michael Secora, our Chief Financial Officer and Nathan Hatfield, our Chief Legal Officer. Also with us are Megan King of PricewaterhouseCoopers LLP, our independent public accountants; Nathan Robinson of Wilson Sonsini Goodrich & Rosati, our outside Corporate Counsel; and Chris Woods, a representative of Broadridge Financial...